NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $16.57 +0.75 (+4.74%) (As of 09/13/2024 08:53 PM ET) Add Compare Share Share Today's Range$16.09▼$16.9150-Day Range$13.65▼$23.2652-Week Range$5.65▼$25.74Volume8.82 million shsAverage Volume7.80 million shsMarket Capitalization$3.56 billionP/E RatioN/ADividend YieldN/APrice Target$19.86 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Hims & Hers Health alerts: Email Address Hims & Hers Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside19.8% Upside$19.86 Price TargetShort InterestBearish17.12% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.47Based on 15 Articles This WeekInsider TradingSelling Shares$13.56 M Sold Last QuarterProj. Earnings Growth72.73%From $0.22 to $0.38 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.99 out of 5 starsMedical Sector365th out of 927 stocksOffices & Clinics Of Medical Doctors Industry3rd out of 8 stocks 3.3 Analyst's Opinion Consensus RatingHims & Hers Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 8 buy ratings, 8 hold ratings, and no sell ratings.Amount of Analyst CoverageHims & Hers Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted17.12% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently increased by 21.70%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HIMS. Previous Next 1.9 News and Social Media Coverage News SentimentHims & Hers Health has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Hims & Hers Health this week, compared to 10 articles on an average week.Search InterestOnly 93 people have searched for HIMS on MarketBeat in the last 30 days. This is a decrease of -41% compared to the previous 30 days.MarketBeat FollowsOnly 8 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -78% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $13,557,329.00 in company stock.Percentage Held by Insiders17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Hims & Hers Health are expected to grow by 72.73% in the coming year, from $0.22 to $0.38 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is -1,657.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is -1,657.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 10.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.Click here to learn more. About Hims & Hers Health Stock (NYSE:HIMS)Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.Read More HIMS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HIMS Stock News HeadlinesSeptember 10, 2024 | marketbeat.comInvest While You Can: Pullbacks on These 3 Stocks Won’t Last Long (HIMS)Three stocks stand out for investors to consider as they recently had big selloffs. There are fundamental reasons to believe that these discounts won't lastSeptember 8, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 188,888 SharesSeptember 16, 2024 | Paradigm Press (Ad)Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.September 6, 2024 | insidertrades.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 2,345 Shares of StockAugust 29, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Director Christiane Pendarvis Sells 7,000 SharesSeptember 13 at 7:17 PM | msn.comDirect-to-Consumer Drugs: Big Pharma's Digital Health PlaySeptember 13 at 3:05 PM | fool.comHims & Hers Stock Pops After Massive AcquisitionSeptember 11, 2024 | fool.comHims & Hers Health Stock Is Crashing: Should You Buy the Dip?September 16, 2024 | Paradigm Press (Ad)Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.September 11, 2024 | fool.comIs Hims & Hers Health the Next Teladoc?September 10, 2024 | fool.comIs Hims & Hers Health Stock a Buy?September 10, 2024 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Receives $20.29 Consensus Price Target from BrokeragesSeptember 8, 2024 | americanbankingnews.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $34,354.25 in StockSeptember 8, 2024 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $169,491.40 in StockSeptember 8, 2024 | americanbankingnews.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) COO Sells $172,122.85 in StockSeptember 6, 2024 | msn.comCommunicator spotlight: Khobi Brooklyn of Hims & HersSeptember 5, 2024 | fool.comGot $1,000? 3 Healthcare Stocks to Buy and Hold ForeverSeptember 4, 2024 | ft.comHealth apps profiting from copycat weight-loss drugs on borrowed timeSee More Headlines Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/05/2024Today9/15/2024Next Earnings (Estimated)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryHealthcare Current SymbolNYSE:HIMS CUSIPN/A CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees1,046Year FoundedN/APrice Target and Rating Average Stock Price Target$19.86 High Stock Price Target$25.00 Low Stock Price Target$10.00 Potential Upside/Downside+19.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E Ratio75.32 P/E GrowthN/ANet Income$-23,550,000.00 Net Margins1.70% Pretax Margin1.98% Return on Equity5.25% Return on Assets4.06% Debt Debt-to-Equity RatioN/A Current Ratio2.68 Quick Ratio2.30 Sales & Book Value Annual Sales$1.07 billion Price / Sales3.34 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book10.29Miscellaneous Outstanding Shares214,786,000Free Float176,747,000Market Cap$3.56 billion OptionableOptionable Beta1.05 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Andrew Dudum (Age 35)Co-Founder, Chairman & CEO Comp: $1.98MMr. Yemi Okupe (Age 38)Chief Financial Officer Comp: $1.01MMs. Melissa Baird (Age 46)Chief Operating Officer Comp: $1.05MMs. Soleil Teubner Boughton (Age 45)Chief Legal Officer & Corporate Secretary Comp: $928.7kDr. Patrick Carroll M.D. (Age 66)Chief Medical Officer, Member of Medical Advisory Board & Director Comp: $54kMr. Mike Chi (Age 44)Chief Commercial Officer Comp: $998kMs. Irene A. Becklund (Age 39)Senior VP, Controller & Principal Accounting Officer Comp: $361.12kMs. Khobi BrooklynChief Communications OfficerMs. Amee ParekhSenior Vice President of Human ResourcesDr. Peter Stahl M.D.Senior VP & Member of Medical Advisory BoardMore ExecutivesKey CompetitorsFresenius Medical CareNYSE:FMSPACS GroupNYSE:PACSOption Care HealthNASDAQ:OPCHSotera HealthNASDAQ:SHCSurgery PartnersNASDAQ:SGRYView All CompetitorsInsiders & InstitutionsCim LLCBought 71,573 shares on 9/6/2024Ownership: 0.033%Sanctuary Advisors LLCBought 20,552 shares on 9/5/2024Ownership: 0.010%Melissa BairdSold 11,749 sharesTotal: $172,122.85 ($14.65/share)Oluyemi OkupeSold 11,609 sharesTotal: $169,491.40 ($14.60/share)Soleil BoughtonSold 2,345 sharesTotal: $34,354.25 ($14.65/share)View All Insider TransactionsView All Institutional Transactions HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $8.90 at the start of the year. Since then, HIMS stock has increased by 86.2% and is now trading at $16.57. View the best growth stocks for 2024 here. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) issued its quarterly earnings data on Monday, August, 5th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.02. Hims & Hers Health's quarterly revenue was up 51.8% on a year-over-year basis. Who are Hims & Hers Health's major shareholders? Hims & Hers Health's top institutional shareholders include Renaissance Technologies LLC (2.81%), Institutional Venture Management XV LLC (1.21%), Dimensional Fund Advisors LP (1.17%) and Marshall Wace LLP (1.03%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Michael Chi, Oluyemi Okupe, Patrick Harrison Carroll, Soleil Boughton, Jules A Maltz, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Jack Abraham and Lynne Chou O'keefe. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:HIMS) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Turn Smartphones Into “Earnphones”?High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And ...Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HIMS Stock Alerts